Vinaginsenoside R4

CAS No. 156009-80-2

Vinaginsenoside R4( —— )

Catalog No. M23675 CAS No. 156009-80-2

Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 373 In Stock
5MG 432 In Stock
10MG 622 In Stock
25MG 938 In Stock
50MG 1265 In Stock
100MG 1702 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vinaginsenoside R4
  • Note
    Research use only, not for human use.
  • Brief Description
    Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.
  • Description
    Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    melanogenic?
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    156009-80-2
  • Formula Weight
    963.16
  • Molecular Formula
    C48H82O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 16.67 mg/mL (17.31 mM)
  • SMILES
    C[C@]12[C@@](C[C@@H](O)[C@@]3([H])[C@]2(CC[C@]3([H])[C@@](CCC=C(C)C)(C)O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)C)([H])[C@@]5([C@@](C(C)([C@@H](O[C@@]6([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O6)O)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO)CC5)C)([H])[C@@H](O)C1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.The potential of minor ginsenosides isolated from the leaves of Panax ginseng as inhibitors of melanogenesis.Int J Mol Sci. 2015 Jan 13;16(1):1677-90.
molnova catalog
related products
  • Substance P (1-7)(TF...

    Substance P (1-7)(TFA) is a fragment of the neuropeptide, substance P (SP).

  • BI SF3

    BI SF3 is an intermediate in the synthesis of heteroarylcarboxamides.

  • BMS986260

    BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM). BMS-986260?demonstrated functional activity in multiple TGFβ-dependent cellular assays, excellent kinome selectivity, favorable pharmacokinetic properties, and curative in vivo efficacy in combination with anti-PD-1 antibody in murine colorectal cancer (CRC) models.?